메뉴 건너뛰기




Volumn 232, Issue 1, 2014, Pages 224-230

Continuation of statin therapy and a decreased risk of atrial fibrillation/flutter in patients with and without chronic kidney disease

Author keywords

Atrial fibrillation; Cohort studies; HMG CoA; Renal insufficiency; Statins

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

EID: 84891614919     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.11.036     Document Type: Article
Times cited : (118)

References (37)
  • 1
    • 79955918190 scopus 로고    scopus 로고
    • High-dose atorvastatin and risk of atrial fibrillation in patients with prior stroke or transient ischemic attack: analysis of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) trial
    • Schwartz G.G., Chaitman B.R., Goldberger J.J., et al. High-dose atorvastatin and risk of atrial fibrillation in patients with prior stroke or transient ischemic attack: analysis of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) trial. Am Heart J 2011, 161:993-999.
    • (2011) Am Heart J , vol.161 , pp. 993-999
    • Schwartz, G.G.1    Chaitman, B.R.2    Goldberger, J.J.3
  • 2
    • 42949123402 scopus 로고    scopus 로고
    • Dose-related effect of statins on atrial fibrillation after cardiac surgery
    • Kourliouros A., De Souza A., Roberts N., et al. Dose-related effect of statins on atrial fibrillation after cardiac surgery. Ann Thorac Surg 2008, 85:1515-1520.
    • (2008) Ann Thorac Surg , vol.85 , pp. 1515-1520
    • Kourliouros, A.1    De Souza, A.2    Roberts, N.3
  • 3
    • 71849109250 scopus 로고    scopus 로고
    • Atrial fibrillation at baseline and during follow-up in ALLHAT (antihypertensive and lipid-lowering treatment to prevent heart attack trial)
    • Haywood L.J., Ford C.E., Crow R.S., et al. Atrial fibrillation at baseline and during follow-up in ALLHAT (antihypertensive and lipid-lowering treatment to prevent heart attack trial). JAm Coll Cardiol 2009, 54:2023-2031.
    • (2009) JAm Coll Cardiol , vol.54 , pp. 2023-2031
    • Haywood, L.J.1    Ford, C.E.2    Crow, R.S.3
  • 4
    • 34447521792 scopus 로고    scopus 로고
    • Role of Rac1 GTPase activation in atrial fibrillation
    • Adam O., Frost G., Custodis F., et al. Role of Rac1 GTPase activation in atrial fibrillation. JAm Coll Cardiol 2007, 50:359-367.
    • (2007) JAm Coll Cardiol , vol.50 , pp. 359-367
    • Adam, O.1    Frost, G.2    Custodis, F.3
  • 5
    • 79952662118 scopus 로고    scopus 로고
    • Severe renal impairment and stroke prevention in atrial fibrillation: implications for thromboprophylaxis and bleeding risk
    • Marinigh R., Lane D.A., Lip G.Y. Severe renal impairment and stroke prevention in atrial fibrillation: implications for thromboprophylaxis and bleeding risk. JAm Coll Cardiol 2011, 57:1339-1348.
    • (2011) JAm Coll Cardiol , vol.57 , pp. 1339-1348
    • Marinigh, R.1    Lane, D.A.2    Lip, G.Y.3
  • 6
    • 78449259952 scopus 로고    scopus 로고
    • Dyslipidemia in chronic kidney disease: are statins still indicated in reduction cardiovascular risk in patients on dialysis treatmentα
    • Scarpioni R., Ricardi M., Melfa L., et al. Dyslipidemia in chronic kidney disease: are statins still indicated in reduction cardiovascular risk in patients on dialysis treatmentα. Cardiovasc Ther 2010, 28:361-368.
    • (2010) Cardiovasc Ther , vol.28 , pp. 361-368
    • Scarpioni, R.1    Ricardi, M.2    Melfa, L.3
  • 7
    • 35548999735 scopus 로고    scopus 로고
    • Statin use and recurrence of atrial fibrillation after successful cardioversion
    • Humphries K.H., Lee M., Sheldon R., et al. Statin use and recurrence of atrial fibrillation after successful cardioversion. Am Heart J 2007, 154:908-913.
    • (2007) Am Heart J , vol.154 , pp. 908-913
    • Humphries, K.H.1    Lee, M.2    Sheldon, R.3
  • 8
    • 36148959362 scopus 로고    scopus 로고
    • Effects of statin therapy on preventing atrial fibrillation in coronary disease and heart failure
    • Adabag A.S., Nelson D.B., Bloomfield H.E. Effects of statin therapy on preventing atrial fibrillation in coronary disease and heart failure. Am Heart J 2007, 154:1140-1145.
    • (2007) Am Heart J , vol.154 , pp. 1140-1145
    • Adabag, A.S.1    Nelson, D.B.2    Bloomfield, H.E.3
  • 9
    • 78650291503 scopus 로고    scopus 로고
    • Preoperative high-dose atorvastatin for prevention of atrial fibrillation after cardiac surgery: a randomized controlled trial
    • Kourliouros A., Valencia O., Hosseini M.T., et al. Preoperative high-dose atorvastatin for prevention of atrial fibrillation after cardiac surgery: a randomized controlled trial. JThorac Cardiovasc Surg 2011, 141:244-248.
    • (2011) JThorac Cardiovasc Surg , vol.141 , pp. 244-248
    • Kourliouros, A.1    Valencia, O.2    Hosseini, M.T.3
  • 10
    • 77953120103 scopus 로고    scopus 로고
    • Association between statin use and the incidence of atrial fibrillation following hospitalization for coronary artery disease
    • Kulik A., Singh J.P., Levin R., et al. Association between statin use and the incidence of atrial fibrillation following hospitalization for coronary artery disease. Am J Cardiol 2010, 105:1655-1660.
    • (2010) Am J Cardiol , vol.105 , pp. 1655-1660
    • Kulik, A.1    Singh, J.P.2    Levin, R.3
  • 11
    • 34548687059 scopus 로고    scopus 로고
    • Observational study on the beneficial effect of preoperative statins in reducing atrial fibrillation after coronary surgery
    • Mariscalco G., Lorusso R., Klersy C., et al. Observational study on the beneficial effect of preoperative statins in reducing atrial fibrillation after coronary surgery. Ann Thorac Surg 2007, 84:1158-1164.
    • (2007) Ann Thorac Surg , vol.84 , pp. 1158-1164
    • Mariscalco, G.1    Lorusso, R.2    Klersy, C.3
  • 12
    • 71149118928 scopus 로고    scopus 로고
    • Non-atheroprotective effects of statins: a systematic review
    • Beri A., Sural N., Mahajan S.B. Non-atheroprotective effects of statins: a systematic review. Am J Cardiovasc Drugs 2009, 9:361-370.
    • (2009) Am J Cardiovasc Drugs , vol.9 , pp. 361-370
    • Beri, A.1    Sural, N.2    Mahajan, S.B.3
  • 13
    • 84885306020 scopus 로고    scopus 로고
    • Dosage of statin, cardiovascular comorbidities, and risk of atrial fibrillation: a nationwide population-based cohort study
    • Hung C.Y., Lin C.H., Wang K.Y., et al. Dosage of statin, cardiovascular comorbidities, and risk of atrial fibrillation: a nationwide population-based cohort study. Int J Cardiol 2013, 168(2):1131-1136.
    • (2013) Int J Cardiol , vol.168 , Issue.2 , pp. 1131-1136
    • Hung, C.Y.1    Lin, C.H.2    Wang, K.Y.3
  • 14
    • 84872584350 scopus 로고    scopus 로고
    • CHADS(2) score, statin therapy, and risks of atrial fibrillation
    • Hung C.Y., Lin C.H., Loh el W., et al. CHADS(2) score, statin therapy, and risks of atrial fibrillation. Am J Med 2013, 126:133-140.
    • (2013) Am J Med , vol.126 , pp. 133-140
    • Hung, C.Y.1    Lin, C.H.2    Loh el, W.3
  • 15
    • 84929511055 scopus 로고    scopus 로고
    • Statin use and risk of atrial fibrillation or flutter: a population-based case-control study
    • Veronese G., Montomoli J., Schmidt M., et al. Statin use and risk of atrial fibrillation or flutter: a population-based case-control study. Am J Ther 2013, 10.1097/MJT.0b013e31827ab488.
    • (2013) Am J Ther
    • Veronese, G.1    Montomoli, J.2    Schmidt, M.3
  • 16
    • 33750561096 scopus 로고    scopus 로고
    • Statins for treatment of dyslipidemia in chronic kidney disease
    • Shurraw S., Tonelli M. Statins for treatment of dyslipidemia in chronic kidney disease. Perit Dial Int 2006, 26:523-539.
    • (2006) Perit Dial Int , vol.26 , pp. 523-539
    • Shurraw, S.1    Tonelli, M.2
  • 17
    • 64249092502 scopus 로고    scopus 로고
    • Cardiovascular disease in patients with renal disease: the role of statins
    • Fellstrom B., Holdaas H., Jardine A.G., et al. Cardiovascular disease in patients with renal disease: the role of statins. Curr Med Res Opin 2009, 25:271-285.
    • (2009) Curr Med Res Opin , vol.25 , pp. 271-285
    • Fellstrom, B.1    Holdaas, H.2    Jardine, A.G.3
  • 18
    • 41549099286 scopus 로고    scopus 로고
    • Statin therapy in peritoneal dialysis patients: effects beyond lipid lowering
    • Paraskevas K.I. Statin therapy in peritoneal dialysis patients: effects beyond lipid lowering. Int Urol Nephrol 2008, 40:165-170.
    • (2008) Int Urol Nephrol , vol.40 , pp. 165-170
    • Paraskevas, K.I.1
  • 19
    • 79960133368 scopus 로고    scopus 로고
    • Sunrise of statins after AURORA and 4Dα
    • Wanner C., Krane V. Sunrise of statins after AURORA and 4Dα. JAm Soc Nephrol 2011, 22:1184-1186.
    • (2011) JAm Soc Nephrol , vol.22 , pp. 1184-1186
    • Wanner, C.1    Krane, V.2
  • 20
    • 22844435378 scopus 로고    scopus 로고
    • Identification of individuals with CKD from Medicare claims data: a validation study
    • Winkelmayer W.C., Schneeweiss S., Mogun H., et al. Identification of individuals with CKD from Medicare claims data: a validation study. Am J Kidney Dis 2005, 46:225-232.
    • (2005) Am J Kidney Dis , vol.46 , pp. 225-232
    • Winkelmayer, W.C.1    Schneeweiss, S.2    Mogun, H.3
  • 21
    • 54749114827 scopus 로고    scopus 로고
    • Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation-a nationwide descriptive study in Taiwan
    • Lin L.J., Cheng M.H., Lee C.H., et al. Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation-a nationwide descriptive study in Taiwan. Clin Ther 2008, 30:1726-1736.
    • (2008) Clin Ther , vol.30 , pp. 1726-1736
    • Lin, L.J.1    Cheng, M.H.2    Lee, C.H.3
  • 22
    • 84857157135 scopus 로고    scopus 로고
    • High-sensitivity C-reactive protein, statin therapy, and risks of atrial fibrillation: an exploratory analysis of the JUPITER trial
    • Pena J.M., MacFadyen J., Glynn R.J., et al. High-sensitivity C-reactive protein, statin therapy, and risks of atrial fibrillation: an exploratory analysis of the JUPITER trial. Eur Heart J 2012, 33:531-537.
    • (2012) Eur Heart J , vol.33 , pp. 531-537
    • Pena, J.M.1    MacFadyen, J.2    Glynn, R.J.3
  • 23
    • 67649831565 scopus 로고    scopus 로고
    • Postoperative inflammatory reaction and atrial fibrillation: simple correlation or causationα
    • Anselmi A., Possati G., Gaudino M. Postoperative inflammatory reaction and atrial fibrillation: simple correlation or causationα. Ann Thorac Surg 2009, 88:326-333.
    • (2009) Ann Thorac Surg , vol.88 , pp. 326-333
    • Anselmi, A.1    Possati, G.2    Gaudino, M.3
  • 25
    • 54949113715 scopus 로고    scopus 로고
    • The impact of statin use on atrial fibrillation
    • Sanchez-Quinones J., Marin F., Roldan V., et al. The impact of statin use on atrial fibrillation. QJM 2008, 101:845-861.
    • (2008) QJM , vol.101 , pp. 845-861
    • Sanchez-Quinones, J.1    Marin, F.2    Roldan, V.3
  • 26
    • 84881309914 scopus 로고    scopus 로고
    • Discontinuation of statin therapy associates with Parkinson disease: a population-based study
    • Lee Y.C., Lin C.H., Wu R.M., et al. Discontinuation of statin therapy associates with Parkinson disease: a population-based study. Neurology 2013, 81:410-416.
    • (2013) Neurology , vol.81 , pp. 410-416
    • Lee, Y.C.1    Lin, C.H.2    Wu, R.M.3
  • 27
    • 84878791450 scopus 로고    scopus 로고
    • Statins of high versus low cholesterol-lowering efficacy and the development of severe renal failure
    • Chung Y.H., Lee Y.C., Chang C.H., et al. Statins of high versus low cholesterol-lowering efficacy and the development of severe renal failure. Pharmacoepidemiol Drug Saf 2013, 10.1002/pds.3433.
    • (2013) Pharmacoepidemiol Drug Saf
    • Chung, Y.H.1    Lee, Y.C.2    Chang, C.H.3
  • 28
    • 77955485289 scopus 로고    scopus 로고
    • Effect of statins on atrial fibrillation after cardiac surgery: a duration- and dose-response meta-analysis
    • Chen W.T., Krishnan G.M., Sood N., et al. Effect of statins on atrial fibrillation after cardiac surgery: a duration- and dose-response meta-analysis. JThorac Cardiovasc Surg 2010, 140:364-372.
    • (2010) JThorac Cardiovasc Surg , vol.140 , pp. 364-372
    • Chen, W.T.1    Krishnan, G.M.2    Sood, N.3
  • 29
    • 78449237306 scopus 로고    scopus 로고
    • Impact of early statin therapy on development of atrial fibrillation at the acute stage of myocardial infarction: data from the FAST-MI register
    • Danchin N., Fauchier L., Marijon E., et al. Impact of early statin therapy on development of atrial fibrillation at the acute stage of myocardial infarction: data from the FAST-MI register. Heart 2010, 96:1809-1814.
    • (2010) Heart , vol.96 , pp. 1809-1814
    • Danchin, N.1    Fauchier, L.2    Marijon, E.3
  • 30
    • 80052602720 scopus 로고    scopus 로고
    • Atrial sources of reactive oxygen species vary with the duration and substrate of atrial fibrillation: implications for the antiarrhythmic effect of statins
    • Reilly S.N., Jayaram R., Nahar K., et al. Atrial sources of reactive oxygen species vary with the duration and substrate of atrial fibrillation: implications for the antiarrhythmic effect of statins. Circulation 2011, 124:1107-1117.
    • (2011) Circulation , vol.124 , pp. 1107-1117
    • Reilly, S.N.1    Jayaram, R.2    Nahar, K.3
  • 31
    • 37549053629 scopus 로고    scopus 로고
    • Effect of statins on collagen type I degradation in patients with coronary artery disease and atrial fibrillation
    • Tziakas D.N., Chalikias G.K., Stakos D.A., et al. Effect of statins on collagen type I degradation in patients with coronary artery disease and atrial fibrillation. Am J Cardiol 2008, 101:199-202.
    • (2008) Am J Cardiol , vol.101 , pp. 199-202
    • Tziakas, D.N.1    Chalikias, G.K.2    Stakos, D.A.3
  • 32
    • 79959746706 scopus 로고    scopus 로고
    • The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (study of heart and renal protection): a randomised placebo-controlled trial
    • Baigent C., Landray M.J., Reith C., et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (study of heart and renal protection): a randomised placebo-controlled trial. Lancet 2011, 377:2181-2192.
    • (2011) Lancet , vol.377 , pp. 2181-2192
    • Baigent, C.1    Landray, M.J.2    Reith, C.3
  • 33
    • 4644272251 scopus 로고    scopus 로고
    • Randomized controlled trial on the efficacy and safety of atorvastatin in patients with type 2 diabetes on hemodialysis (4D study): demographic and baseline characteristics
    • Wanner C., Krane V., Marz W., et al. Randomized controlled trial on the efficacy and safety of atorvastatin in patients with type 2 diabetes on hemodialysis (4D study): demographic and baseline characteristics. Kidney Blood Press Res 2004, 27:259-266.
    • (2004) Kidney Blood Press Res , vol.27 , pp. 259-266
    • Wanner, C.1    Krane, V.2    Marz, W.3
  • 34
    • 63849163945 scopus 로고    scopus 로고
    • Rosuvastatin and cardiovascular events in patients undergoing hemodialysis
    • Fellstrom B.C., Jardine A.G., Schmieder R.E., et al. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. NEngl J Med 2009, 360:1395-1407.
    • (2009) NEngl J Med , vol.360 , pp. 1395-1407
    • Fellstrom, B.C.1    Jardine, A.G.2    Schmieder, R.E.3
  • 35
    • 79960667212 scopus 로고    scopus 로고
    • The role of statins in chronic kidney disease
    • Kalaitzidis R.G., Elisaf M.S. The role of statins in chronic kidney disease. Am J Nephrol 2011, 34:195-202.
    • (2011) Am J Nephrol , vol.34 , pp. 195-202
    • Kalaitzidis, R.G.1    Elisaf, M.S.2
  • 36
    • 78650184434 scopus 로고    scopus 로고
    • Study of heart and renal protection (SHARP): randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease
    • 785-794 e710
    • Sharp Collaborative G. Study of heart and renal protection (SHARP): randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease. Am Heart J 2010, 160. 785-794 e710.
    • (2010) Am Heart J , vol.160
    • Sharp Collaborative, G.1
  • 37
    • 79958107533 scopus 로고    scopus 로고
    • Statins and lipid-lowering strategies in cardiorenal patients
    • Bianchi S., Grimaldi D., Bigazzi R. Statins and lipid-lowering strategies in cardiorenal patients. Contrib Nephrol 2011, 171:143-150.
    • (2011) Contrib Nephrol , vol.171 , pp. 143-150
    • Bianchi, S.1    Grimaldi, D.2    Bigazzi, R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.